CXCL12 and atherosclerosis: Experimental studies indicated that increased SDF-1 could induce neointimal hyperplasia and angiogenesis, triggers vascular inflammatory response, aggravates insulin resistance, and is associated with atherosclerosis and cardiovascular events [1–7].